Match!

Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans

Published on Aug 1, 2017in Cell Metabolism22.415
· DOI :10.1016/j.cmet.2017.07.008
Norbert Stefan64
Estimated H-index: 64
(University of Tübingen),
Fritz Schick64
Estimated H-index: 64
(University of Tübingen),
Hu Häring88
Estimated H-index: 88
(University of Tübingen)
Sources
Abstract
A BMI in the normal range associates with a decreased risk of cardiometabolic disease and all-cause mortality. However, not all subjects in this BMI range have this low risk. Compared to people who are of normal weight and metabolically healthy, subjects who are of normal weight but metabolically unhealthy (∼20% of the normal weight adult population) have a greater than 3-fold higher risk of all-cause mortality and/or cardiovascular events. Here we address to what extent major risk phenotypes determine metabolic health in lean compared to overweight and obese people and provide support for the existence of a lipodystrophy-like phenotype in the general population. Furthermore, we highlight the molecular mechanisms that induce this phenotype. Finally, we propose strategies as to how this knowledge could be implemented in the prevention and treatment of cardiometabolic diseases in different stages of adiposity in routine clinical practice.
Figures & Tables
  • References (83)
  • Citations (69)
📖 Papers frequently viewed together
57 Citations
71 Citations
219 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References83
Newest
#1Unjali P. Gujral (Emory University)H-Index: 6
#2Eric Vittinghoff (UCSF: University of California, San Francisco)H-Index: 104
Last. Alka M. Kanaya (UCSF: University of California, San Francisco)H-Index: 53
view all 10 authors...
Background:The relationship between body weight and cardiometabolic disease may vary substantially by race/ethnicity. Objective:To determine the prevalence and correlates of the phenotype of metabolic abnormality but normal weight (MAN) for 5 racial/ethnic groups. Design:Cross-sectional analysis. Setting:2 community-based cohorts. Participants:2622 white, 803 Chinese American, 1893 African American, and 1496 Hispanic persons from MESA (Multi-Ethnic Study of Atherosclerosis) and 803 South Asian p...
19 CitationsSource
In recent years, different subphenotypes of obesity have been described, including metabolically healthy obesity (MHO), in which a proportion of obese individuals, despite excess body fat, remain free of metabolic abnormalities and increased cardiometabolic risk. In the absence of a universally accepted set of criteria to classify MHO, the reported prevalence estimates vary widely. Our understanding of the determinants and stability of MHO over time and the associated cardiometabolic and mortali...
49 CitationsSource
#1Luca A. Lotta (University of Cambridge)H-Index: 14
#2Pawan Gulati (University of Cambridge)H-Index: 10
Last. Rob Scott (University of Cambridge)H-Index: 89
view all 30 authors...
150 CitationsSource
#1Robert RossH-Index: 51
#2Steven N. BlairH-Index: 142
Last. Ulrik WisløffH-Index: 69
view all 16 authors...
Mounting evidence has firmly established that low levels of cardiorespiratory fitness (CRF) are associated with a high risk of cardiovascular disease, all-cause mortality, and mortality rates attributable to various cancers. A growing body of epidemiological and clinical evidence demonstrates not only that CRF is a potentially stronger predictor of mortality than established risk factors such as smoking, hypertension, high cholesterol, and type 2 diabetes mellitus, but that the addition of CRF t...
279 CitationsSource
#1Ulf Smith (University of Gothenburg)H-Index: 84
#2Barbara B. Kahn (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 111
Obesity, the major cause of the current global epidemic of type 2 diabetes (T2D), induces insulin resistance in peripheral insulin target tissues. Several mechanisms have been identified related to cross-talk between adipose tissue, skeletal muscle and liver. These mechanisms involve both increased free fatty acid release and altered secretion of adipokines from adipose tissue. A major determinant of metabolic health is the ability of subcutaneous adipose tissue (SAT) to store excess fat rather ...
73 CitationsSource
#1C. M. KusminskiH-Index: 8
#2Perry E. BickelH-Index: 26
Last. Philipp E. SchererH-Index: 112
view all 3 authors...
Adipose tissue may become severely dysfunctional during obesity, resulting in disrupted metabolic homeostasis and ultimately type 2 diabetes. Here, Scherer and colleagues provide an overview of adipose tissue development, function and homeostasis, focusing on emerging potential strategies for targeting this organ in the treatment of obesity-associated diabetes.
152 CitationsSource
#1Norbert Stefan (University of Tübingen)H-Index: 64
#2Andreas Fritsche (University of Tübingen)H-Index: 72
Last. Hu Häring (University of Tübingen)H-Index: 88
view all 4 authors...
71 CitationsSource
#2Shilpa N. Bhupathiraju (UoB: University of Bristol)H-Index: 24
Last. Frank B. HuH-Index: 205
view all 61 authors...
Summary Background Overweight and obesity are increasing worldwide. To help assess their relevance to mortality in different populations we conducted individual-participant data meta-analyses of prospective studies of body-mass index (BMI), limiting confounding and reverse causality by restricting analyses to never-smokers and excluding pre-existing disease and the first 5 years of follow-up. Methods Of 10 625 411 participants in Asia, Australia and New Zealand, Europe, and North America from 23...
478 CitationsSource
#1Hanieh Yaghootkar (University of Exeter)H-Index: 30
#2Luca A. Lotta (University of Cambridge)H-Index: 14
Last. Timothy M. Frayling (University of Exeter)H-Index: 103
view all 25 authors...
Recent genetic studies have identified some alleles that are associated with higher BMI but lower risk of type 2 diabetes, hypertension, and heart disease. These “favorable adiposity” alleles are collectively associated with lower insulin levels and higher subcutaneous–to–visceral adipose tissue ratio and may protect from disease through higher adipose storage capacity. We aimed to use data from 164,609 individuals from the UK Biobank and five other studies to replicate associations between a ge...
45 CitationsSource
#1Steven P. Marso (UTSW: University of Texas Southwestern Medical Center)H-Index: 47
#2Gilbert H. Daniels (Harvard University)H-Index: 44
Last. John B. Buse (UNC: University of North Carolina at Chapel Hill)H-Index: 97
view all 15 authors...
BackgroundThe cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients with type 2 diabetes, remains unknown. MethodsIn this double-blind trial, we randomly assigned patients with type 2 diabetes and high cardiovascular risk to receive liraglutide or placebo. The primary composite outcome in the time-to-event analysis was the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. The prima...
1,905 CitationsSource
Cited By69
Newest
#1Yilin Song (Mayo Clinic)
#2Esben Søndergaard (Mayo Clinic)H-Index: 11
Last. Michael Dennis Jensen (Mayo Clinic)H-Index: 68
view all 3 authors...
PURPOSE: Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) and Adipose Insulin Resistance index (ADIPO-IR) values are often concordant. In this study we evaluated whether there are groups discordant for HOMA-IR and ADIPOpalmitate-IR and, if so, what are their defining characteristics. METHODS: The body composition, basal metabolic rate (BMR), fasting plasma lipids, insulin, glucose and free fatty acid (FFA) palmitate concentrations data of 466 volunteers from previous research studie...
Source
Summary An increase in fat mass is considered to be an important risk factor for the worldwide increase in type 2 diabetes and cardiovascular disease. However, for a given fat mass, there is a large variability in the risk prediction of these cardiometabolic diseases. For example, some lean people unexpectedly have a risk of type 2 diabetes and cardiovascular disease that is similar to the increased risk that is observed in most people who have obesity. What both of these phenotypes have in comm...
1 CitationsSource
#1Hosung BaeH-Index: 5
#2Ki Yong Hong (Dongguk University)H-Index: 2
Last. Gou Young Koh (KAIST)H-Index: 59
view all 10 authors...
Proper storage of excessive dietary fat into subcutaneous adipose tissue (SAT) prevents ectopic lipid deposition-induced insulin resistance, yet the underlying mechanism remains unclear. Here, we identify angiopoietin-2 (Angpt2)–integrin α5β1 signaling as an inducer of fat uptake specifically in SAT. Adipocyte-specific deletion of Angpt2 markedly reduced fatty acid uptake and storage in SAT, leading to ectopic lipid accumulation in glucose-consuming organs including skeletal muscle and liver and...
Source
Introduction On the last three months the new SARS-COV-2 coronavirus has created a pandemic, rapidly spreading all around the world The aim of the study is to investigate whether obesity impacts on COVID-19 morbidity Methods One hundred consecutive patients with COVID-19 pneumonia admitted in our Medical Unit were evaluated Anthropometric parameters and past medical history were registered Nasopharyngeal swab samples and biochemical analysis were obtained at admission and during hospital stay Re...
1 CitationsSource
#1Cristina Sánchez‐González (CSIC: Spanish National Research Council)
#2Cristina Nuevo-Tapioles (UAM: Autonomous University of Madrid)H-Index: 3
Last. Laura Formentini (UAM: Autonomous University of Madrid)H-Index: 20
view all 8 authors...
It is controversial whether mitochondrial dysfunction in skeletal muscle is the cause or consequence of metabolic disorders. Herein, we demonstrate that in vivo inhibition of mitochondrial ATP synthase in muscle alters whole-body lipid homeostasis. Mice with restrained mitochondrial ATP synthase activity presented intrafiber lipid droplets, dysregulation of acyl-glycerides, and higher visceral adipose tissue deposits, poising these animals to insulin resistance. This mitochondrial energy crisis ...
Source
#1Ken Yoshida (Jichi Medical University)H-Index: 1
#2Kazuha Yokota (Jichi Medical University)H-Index: 1
Last. Yosuke Kawai (UTokyo: University of Tokyo)H-Index: 12
view all 12 authors...
Source
: The prevalence of nonalcoholic fatty liver disease (NAFLD) continues to increase worldwide, presently affecting 25% of the adult population, and is associated with an elevated risk of total and liver-specific mortality. NAFLD is a chronic disease and results from a combination of genetic, environmental and predominantly lifestyle-related causes. Therefore, NAFLD, similarly to cardiovascular disease, type 2 diabetes and many different types of cancer, can be considered a noncommunicable disease...
Source
#1Mohammed Eslam (USYD: University of Sydney)H-Index: 14
#2Jian-Gao Fan (SJTU: Shanghai Jiao Tong University)
Last. Nahum Méndez-Sánchez (UNAM: National Autonomous University of Mexico)H-Index: 3
view all 3 authors...
Source
#1Matthias Blüher (Leipzig University)H-Index: 79
Obesity contributes to reduced life expectancy, impaired quality of life and disabilities mainly in those individuals who develop cardiovascular diseases, type 2 diabetes, osteoarthritis and cancer. However, there is large variation in the individual risk to develop obesity-associated comorbid diseases which cannot simply be explained by the extent of adiposity. Observations that a proportion of individuals with obesity have a significantly lower risk for cardiometabolic abnormalities led to the...
1 CitationsSource
#2Elena SuccurroH-Index: 21
Last. Giorgio Sesti (Sapienza University of Rome)H-Index: 55
view all 6 authors...
INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is associated cardiovascular disease (CVD) in patients with type 2 diabetes; nonetheless, it is unknown whether the relationship between NAFLD and CVD occurs also in subjects with prediabetes. Herein, we evaluated whether NAFLD is associated with prevalent CVD in subjects with different glucose tolerance states independently of cardiovascular risk factors. MATERIALS AND METHODS: Presence of NALFD, defined by liver ultrasound, and its associ...
Source